Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Significant heterogeneity of clinical presentation and disease progression exists within chronic obstructive pulmonary disease (COPD). Although FEV(1) inadequately describes this heterogeneity, a clear alternative has not emerged. The goal of phenotyping is to identify patient groups with unique prognostic or therapeutic characteristics, but significant variation and confusion surrounds use of the term "phenotype" in COPD. Phenotype classically refers to any observable characteristic of an organism, and up until now, multiple disease characteristics have been termed COPD phenotypes. We, however, propose the following variation on this definition: "a single or combination of disease attributes that describe differences between individuals with COPD as they relate to clinically meaningful outcomes (symptoms, exacerbations, response to therapy, rate of disease progression, or death)." This more focused definition allows for classification of patients into distinct prognostic and therapeutic subgroups for both clinical and research purposes. Ideally, individuals sharing a unique phenotype would also ultimately be determined to have a similar underlying biologic or physiologic mechanism(s) to guide the development of therapy where possible. It follows that any proposed phenotype, whether defined by symptoms, radiography, physiology, or cellular or molecular fingerprint will require an iterative validation process in which "candidate" phenotypes are identified before their relevance to clinical outcome is determined. Although this schema represents an ideal construct, we acknowledge any phenotype may be etiologically heterogeneous and that any one individual may manifest multiple phenotypes. We have much yet to learn, but establishing a common language for future research will facilitate our understanding and management of the complexity implicit to this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · cited 1×
“On the one hand, COPD is defined by the presence of airflow limitation that is not fully reversible, and its treatment is mostly guided by the severity of this limitation (1).”
BackgroundSelf-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 4×
“Perhaps best well known of these is the BODE Index to predict mortality, which incorporates dyspnea, BMI, FEV1, and exercise capacity as measured by 6-minute walk distance (6MWD).”
BackgroundMethodInfluentialSelf-citationThe natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030287 · Cited by 2,071
Gan, W. Q. (2004) · Thorax · doi:10.1136/thx.2003.019588 · Cited by 1,838
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Systemic effects of chronic obstructive pulmonary disease
Agustí, A. G. N., Noguera, A., Sauleda, J., Sala, E., Pons, J., & Busquets, X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00405703 · Cited by 1,045
Toward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Calverley, P. M., Rabe, K. F., Goehring, U.-M., Kristiansen, S., Fabbri, L. M., & Martinez, F. J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61255-1 · Cited by 829
Self-citationComputed Tomographic Measurements of Airway Dimensions and Emphysema in Smokers
NAKANO, Y., MURO, S., SAKAI, H., HIRAI, T., CHIN, K., TSUKINO, M., NISHIMURA, K., ITOH, H., PARÉ, P. D., HOGG, J. C., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9907120 · Cited by 695 · cited 1×
“Objective measures of proximal airway wall thickening obtained via CT are inversely correlated with lung function and relate to a subject’s burden of small airway disease (26) and exacerbation frequency (27).”
BackgroundCOPD as a Disease of Accelerated Lung Aging
Ito, K., & Barnes, P. J. (2009) · Chest · doi:10.1378/chest.08-1419 · Cited by 629
Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care
Soriano, J. B., Visick, G. T., Muellerova, H., Payvandi, N., & Hansell, A. L. (2005) · Chest · doi:10.1378/chest.128.4.2099 · Cited by 615 · cited 1×
“Patients with COPD often present with comorbid diseases, including cardiovascular disease, metabolic syndrome, osteoporosis, depression, and skeletal muscle wasting and dysfunction (46, 47).”
BackgroundCasanova, C., Cote, C., de Torres, J. P., Aguirre-Jaime, A., Marin, J. M., Pinto-Plata, V., & Celli, B. R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-867oc · Cited by 597 · cited 1×
“Hyperinflation may also define patient groups associated with varying mortality or functional impairment (17, 18).”
BackgroundSelf-citationHealth status measurement in chronic obstructive pulmonary disease
Jones, P. W. (2001) · Thorax · doi:10.1136/thorax.56.11.880 · Cited by 557
Self-citationRelationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD
Stockley, R. A., O’Brien, C., Pye, A., & Hill, S. L. (2000) · Chest · doi:10.1378/chest.117.6.1638 · Cited by 535
Puhan, M. A., Garcia-Aymerich, J., Frey, M., ter Riet, G., Antó, J. M., Agustí, A. G., Gómez, F. P., Rodríguez-Roisín, R., Moons, K. G., Kessels, A. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61301-5 · Cited by 521
O'DONNELL, D. E., LAM, M., & WEBB, K. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9901038 · Cited by 485 · cited 1×
“Hyperinflation may also define patient groups associated with varying mortality or functional impairment (17, 18).”
BackgroundPredictors of Mortality in Patients with Emphysema and Severe Airflow Obstruction
Martinez, F. J., Foster, G., Curtis, J. L., Criner, G., Weinmann, G., Fishman, A., DeCamp, M. M., Benditt, J., Sciurba, F., Make, B., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1677oc · Cited by 446
Self-citationAirflow Limitation and Airway Dimensions in Chronic Obstructive Pulmonary Disease
Hasegawa, M., Nasuhara, Y., Onodera, Y., Makita, H., Nagai, K., Fuke, S., Ito, Y., Betsuyaku, T., & Nishimura, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-037oc · Cited by 413
Watz, H., Waschki, B., Boehme, C., Claussen, M., Meyer, T., & Magnussen, H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1011oc · Cited by 368
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
Burgel, P.-R., Paillasseur, J.-L., Caillaud, D., Tillie-Leblond, I., Chanez, P., Escamilla, R., Court-Fortune, I., Perez, T., Carré, P., & Roche, N. (2010) · European Respiratory Journal · doi:10.1183/09031936.00175109 · Cited by 358
Gender and Chronic Obstructive Pulmonary Disease: Why It Matters
Han, M. K., Postma, D., Mannino, D. M., Giardino, N. D., Buist, S., Curtis, J. L., & Martinez, F. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-553cc · Cited by 353
Self-citationEffects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Lacy, P., York, E., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 347
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346
Inflammation markers predicting frailty and mortality in the elderly
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.11.004 · Cited by 345
Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients
Soler-Cataluña, J. J., Martínez-García, M. Á., Sánchez, L. S., Tordera, M. P., & Sánchez, P. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.12.005 · Cited by 309
Kinsella, M., Müller, N. L., Abboud, R. T., Morrison, N. J., & DyBuncio, A. (1990) · Chest · doi:10.1378/chest.97.2.315 · Cited by 298
Triple-negative/basal-like breast cancer: review
Rakha, E. A., & Ellis, I. O. (2009) · Pathology · doi:10.1080/00313020802563510 · Cited by 281
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation
Crisafulli, E., Costi, S., Luppi, F., Cirelli, G., Cilione, C., Coletti, O., Fabbri, L. M., & Clini, E. M. (2008) · Thorax · doi:10.1136/thx.2007.086371 · Cited by 272
Self-citationJones, R. C., Donaldson, G. C., Chavannes, N. H., Kida, K., Dickson-Spillmann, M., Harding, S., Wedzicha, J. A., Price, D., & Hyland, M. E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0271oc · Cited by 262
Dahlén, I., & Janson, C. (2002) · Chest · doi:10.1378/chest.122.5.1633 · Cited by 254
Distinct clinical phenotypes of airways disease defined by cluster analysis
Weatherall, M., Travers, J., Shirtcliffe, P. M., Marsh, S. E., Williams, M. V., Nowitz, M. R., Aldington, S., & Beasley, R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00174408 · Cited by 246
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Ferguson, G. T., Anzueto, A., Fei, R., Emmett, A., Knobil, K., & Kalberg, C. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.019 · Cited by 232
Sin, D. D., Man, S. F. P., Marciniuk, D. D., Ford, G., FitzGerald, M., Wong, E., York, E., Mainra, R. R., Ramesh, W., Melenka, L. S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1356oc · Cited by 212
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Pinto-Plata, V., Toso, J., Lee, K., Park, D., Bilello, J., Mullerova, H., De Souza, M. M., Vessey, R., & Celli, B. (2007) · Thorax · doi:10.1136/thx.2006.064428 · Cited by 205
Self-citationContribution of Emphysema and Small Airways in COPD
Gelb, A. F., Hogg, J. C., Müller, N. L., Schein, M. J., Kuei, J., Tashkin, D. P., Epstein, J. D., Kollin, J., Green, R. H., Zamel, N., et al. (1996) · Chest · doi:10.1378/chest.109.2.353 · Cited by 190
Owens, G. R., Rogers, R. M., Pennock, B. E., & Levin, D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101903 · Cited by 181
Physiological changes during symptom recovery from moderate exacerbations of COPD
Parker, C. M., Voduc, N., Aaron, S. D., Webb, K. A., & O'Donnell, D. E. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00136304 · Cited by 176
Chronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease
van Eeden, S. F., & Sin, D. D. (2007) · Respiration · doi:10.1159/000111820 · Cited by 168
The Radiologic Manifestations of Legionnaire's Disease
Tan, M. J., Tan, J. S., File, T. M., Hamor, R. H., & Breiman, R. F. (2000) · Chest · doi:10.1378/chest.117.2.398 · Cited by 166
Phenotypes of Chronic Obstructive Pulmonary Disease
Friedlander, A. L., Lynch, D. A., Dyar, L. A., & Bowler, R. P. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701629663 · Cited by 152
The modified BODE index: validation with mortality in COPD
Côté, C., Pinto-Plata, V., Marín, J. M., Nekach, H., Dordelly, L. J., & Celli, B. R. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138507 · Cited by 152
Self-citationDoll, H., & Miravitlles, M. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523040-00005 · Cited by 131
Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease
Hersh, C. P., DeMeo, D. L., Lazarus, R., Celedón, J. C., Raby, B. A., Benditt, J. O., Criner, G., Make, B., Martinez, F. J., Scanlon, P. D., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1452oc · Cited by 129
Self-citationRice, J. P., Saccone, N. L., & Rasmussen, E. (2001) · Advances in genetics · doi:10.1016/s0065-2660(01)42015-3 · Cited by 105
The Association Between Depressive Symptoms and Acute Exacerbations of COPD
Jennings, J. H., DiGiovine, B., Obeid, D., & Frank, C. (2009) · Lung · doi:10.1007/s00408-009-9135-9 · Cited by 99
Clinical Significance of Radiologic Characterizations in COPD
Han, M. K., Bartholmai, B. J., Liu, L. X., Murray, S., Curtis, J. L., Sciurba, F. C., Kazerooni, E. A., Thompson, B., Frederick, M., Li, D., et al. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903341513 · Cited by 95
Self-citationWise, R. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.002 · Cited by 90
Briggs, A. H. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.37 · Cited by 90
Eosinophils in Asthma — Closing the Loop or Opening the Door?
Wenzel, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejme0900334 · Cited by 81
Cho, M., Washko, G. R., Hoffmann, T. J., Criner, G. J., Hoffman, E. A., Martínez, F. J., Laird, N. M., Reilly, J. J., & Silverman, E. K. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-30 · Cited by 81
Self-citationPrevalence and clinical correlates of bronchoreversibility in severe emphysema
Han, M.-L. K., Wise, R., Mumford, J. A., Sciurba, F., Criner, G., Curtis, J., Murray, S., Sternberg, A., Weinman, G., Kazerooni, E., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00052509 · Cited by 62
Self-citationExercise Testing in Severe Emphysema: Association with Quality of Life and Lung Function
Brown, C. D., Benditt, J. O., Sciurba, F. C., Lee, S. M., Criner, G. J., Mosenifar, Z., Shade, D. M., Slivka, W. A., & Wise, R. A. (2008) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550801941265 · Cited by 59
Self-citationDeterminants of Maximum Exercise Capacity in Patients with Chronic Airflow Obstruction
Dillard, T. A., Piantadosi, S., & Rajagopal, K. R. (1989) · CHEST Journal · doi:10.1378/chest.96.2.267 · Cited by 55
Paoletti, M., Camiciottoli, G., Meoni, E., Bigazzi, F., Cestelli, L., Pistolesi, M., & Marchesi, C. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2009.05.008 · Cited by 50
Bon, J. M., Leader, J. K., Weissfeld, J. L., Coxson, H. O., Zheng, B., Branch, R. A., Kondragunta, V., Lee, J. S., Zhang, Y., Choi, A. M. K., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006865 · Cited by 49
Self-citationExacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression?
Silverman, E. K. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200706-068th · Cited by 43
Self-citationShah, A. S. M., Anshar, F. M., Faizal, M. P. A., Zaharim, A., Roslina, A. M., & Harun, R. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.052399 · Cited by 43
Mahler, D., Ward, J., Fierro-Carrion, G. A., Waterman, L. A., Lentine, T., Mejía-Alfaro, R., & Baird, J. (2004) · COPD · doi:10.1081/copd-120030829 · Cited by 35
Devanarayan, V., Scholand, M.-B., Hoidal, J. R., Leppert, M., Crackower, M. A., O’Neill, G. P., & Gervais, F. G. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412550903499530 · Cited by 22
Cited by
Characterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Agustí, A., Edwards, L. D., Rennard, S. I., MacNee, W., Tal-Singer, R., Miller, B. E., Vestbo, J., Lomas, D. A., Calverley, P. M. A., Wouters, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037483 · Cited by 848
Self-citationGalbán, C. J., Han, M. K., Boes, J. L., Chughtai, K. A., Meyer, C. R., Johnson, T. D., Galbán, S., Rehemtulla, A., Kazerooni, E. A., Martinez, F. J., et al. (2012) · Nature Medicine · doi:10.1038/nm.2971 · Cited by 813
Self-citationAdvances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Flume, P. A., Chalmers, J. D., & Olivier, K. N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31767-7 · Cited by 545
Metadata
- Authors
- Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., Make, B. J., Rabe, K. F., Rennard, S. I., Sciurba, F. C., Silverman, E. K., Vestbo, J., Washko, G. R., Wouters, E. F. M., & Martinez, F. J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-01
- Volume
- 182
- Issue
- 5
- Pages
- 598-604
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1859222707
- Cited by
- 1,032
- References
- 62
- FWCI
- 68.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.